The National Institute of Health reports more than 115 people in the U.S. die every day, or someone every 11 minutes, after overdosing on opioids. The Centers for Disease Control and Prevention estimates the total economic burden of prescription opioid misuse alone in the U.S. is $78.5 billion a year. ScripGuard is designed to compel patient compliance with prescription opioid medication use and minimize opioid overdose or misuse.
ScripGuard is intended to proactively address the opioid crisis in the United States, and ultimately, worldwide. The device is designed to compel patient compliance with prescription opioid medication use. It will also minimize unauthorized medication use by non-patients. ScripGuard will be ordered by a physician, filled and locked by the pharmacist, and only allow a single medication dosage to be accessible to the patient at the required time. The patient will be required to return the device with unused medication to the pharmacy for proper disposal. The device will be reusable and tampering or misuse of the device can be reported to the physician.
Willett Enterprise, Inc and ScripGuard have been awarded three grants from the Sandra Day O’Connor College of Law at Arizona State University. The first was from the Lisa Patent Foundation with filing for a federal patent in December, 2019. The second and third grants were from the Innovation and Advancement Program. These included legal analysis, including FDA analysis, an operating agreement, independent contractor agreement, HIPPA analysis, licensing agreements, and product liability.
Bradley Willett, Founder of ScripGuard, is a 2018 graduate of Arizona State University and the W.P. Carey School of Business. He is an entrepreneur whose passion is finding innovative solutions to medical issues, including the opioid crisis.